These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17760415)

  • 21. Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors.
    Zhang H; Chen J; Waldherr C; Hinni K; Waser B; Reubi JC; Maecke HR
    Cancer Res; 2004 Sep; 64(18):6707-15. PubMed ID: 15374988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
    Moustapha ME; Ehrhardt GJ; Smith CJ; Szajek LP; Eckelman WC; Jurisson SS
    Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fast cancer uptake of 99mTc-labelled bombesin (99mTc BN1).
    Scopinaro F; Di Santo GP; Tofani A; Massari R; Trotta C; Ragone M; Archimandritis S; Varvarigou AD
    In Vivo; 2005; 19(6):1071-6. PubMed ID: 16277024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent pseudopeptide bombesin-like agonists and antagonists. Correlation of ordered conformation of bombesin analogs to receptor activity.
    Edwards JV; McLean LR; Wade AC; Eaton SR; Cashman EA; Hagaman KA; Fanger BO
    Int J Pept Protein Res; 1994 Apr; 43(4):374-83. PubMed ID: 8045684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study.
    Nock BA; Nikolopoulou A; Galanis A; Cordopatis P; Waser B; Reubi JC; Maina T
    J Med Chem; 2005 Jan; 48(1):100-10. PubMed ID: 15634004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog.
    Schuhmacher J; Zhang H; Doll J; Mäcke HR; Matys R; Hauser H; Henze M; Haberkorn U; Eisenhut M
    J Nucl Med; 2005 Apr; 46(4):691-9. PubMed ID: 15809493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and radiopharmacological evaluation of ⁶⁴Cu-labeled bombesin analogs featuring a bis(2-pyridylmethyl)-1,4,7-triazacyclononane chelator.
    Bergmann R; Ruffani A; Graham B; Spiccia L; Steinbach J; Pietzsch J; Stephan H
    Eur J Med Chem; 2013; 70():434-46. PubMed ID: 24184988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bombesin receptor antagonists may be preferable to agonists for tumor targeting.
    Cescato R; Maina T; Nock B; Nikolopoulou A; Charalambidis D; Piccand V; Reubi JC
    J Nucl Med; 2008 Feb; 49(2):318-26. PubMed ID: 18199616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors.
    La Bella R; Garcia-Garayoa E; Langer M; Bläuenstein P; Beck-Sickinger AG; Schubiger PA
    Nucl Med Biol; 2002 Jul; 29(5):553-60. PubMed ID: 12088725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kit formulation for 99mTc-labeling of HYNIC-βAla-Bombesin((7-14)).
    de Barros AL; Mota Ld; Ferreira Cde A; Cardoso VN
    Appl Radiat Isot; 2012 Oct; 70(10):2440-5. PubMed ID: 22871450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
    von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
    Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells.
    Hoffman TJ; Gali H; Smith CJ; Sieckman GL; Hayes DL; Owen NK; Volkert WA
    J Nucl Med; 2003 May; 44(5):823-31. PubMed ID: 12732685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer takes up 99mTc bombesin. A preliminary report.
    Scopinaro F; Varvarigou A; Ussof W; De Vincentis G; Archimandritis S; Evangelatos G; Corleto V; Pulcini A; Capoccetti F; Remediani S; Massa R
    Tumori; 2002; 88(3):S25-8. PubMed ID: 12365377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs.
    Maina T; Nock BA; Zhang H; Nikolopoulou A; Waser B; Reubi JC; Maecke HR
    J Nucl Med; 2005 May; 46(5):823-30. PubMed ID: 15872357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues.
    Baidoo KE; Lin KS; Zhan Y; Finley P; Scheffel U; Wagner HN
    Bioconjug Chem; 1998; 9(2):218-25. PubMed ID: 9548537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging.
    Nock B; Nikolopoulou A; Chiotellis E; Loudos G; Maintas D; Reubi JC; Maina T
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):247-58. PubMed ID: 12552343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
    Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ
    Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent.
    Karra SR; Schibli R; Gali H; Katti KV; Hoffman TJ; Higginbotham C; Sieckman GL; Volkert WA
    Bioconjug Chem; 1999; 10(2):254-60. PubMed ID: 10077475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes.
    Smith CJ; Volkert WA; Hoffman TJ
    Nucl Med Biol; 2005 Oct; 32(7):733-40. PubMed ID: 16243649
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.